Fang Xia Selected Research

Fang Xia Research Topics

Disease

16	Neoplasms (Cancer) 11/2022 - 05/2005
3	Obesity 01/2016 - 01/2015
2	Pain (Aches) 05/2024 - 11/2012
2	Pneumonia (Pneumonitis) 06/2023 - 12/2022
2	Sarcoma (Soft Tissue Sarcoma) 10/2022 - 06/2022
2	Colorectal Neoplasms (Colorectal Cancer) 10/2022 - 06/2022
2	Lung Neoplasms (Lung Cancer) 08/2020 - 01/2019
2	Hyperglycemia 02/2019 - 01/2011
2	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 01/2007
2	Infections 04/2015 - 04/2006
2	Body Weight (Weight, Body) 08/2007 - 01/2007
1	Osteoporosis 05/2024
1	Albuminuria 01/2023
1	Latent Tuberculosis 01/2023
1	Cytokine Release Syndrome 01/2023
1	Severe Fever with Thrombocytopenia Syndrome 01/2023
1	Inflammation (Inflammations) 12/2022
1	Diabetic Nephropathies (Diabetic Nephropathy) 11/2022
1	Brain Neoplasms (Brain Tumor) 10/2022
1	Thyroid Neoplasms (Thyroid Cancer) 06/2022
1	Diabetes Mellitus 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Osteoarthritis 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2020
1	Abdominal Pain (Pain, Abdominal) 07/2020
1	Ketosis 07/2020
1	Atherosclerosis 11/2019
1	Glaucoma 02/2019
1	Lung Diseases (Lung Disease) 01/2019
1	Adenocarcinoma of Lung 06/2017
1	Glucose Intolerance 01/2016
1	Heart Diseases (Heart Disease) 01/2015
1	Stomach Neoplasms (Stomach Cancer) 12/2014
1	Stomach Diseases 12/2014
1	Disease Progression 12/2014
1	Fatigue 02/2014
1	Hypoxia (Hypoxemia) 05/2013
1	Brain Injuries (Brain Injury) 05/2013
1	Ischemia 05/2013

Drug/Important Bio-Agent (IBA)

5	SurvivinIBA 05/2011 - 04/2006
3	larotrectinibIBA 10/2022 - 08/2020
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2014
3	Transcription Factors (Transcription Factor)IBA 07/2011 - 02/2003
2	Therapeutic UsesIBA 05/2024 - 01/2007
2	LipopolysaccharidesIBA 06/2023 - 12/2022
2	TNF Receptor-Associated Factor 1IBA 06/2023 - 12/2022
2	CreatinineIBA 01/2023 - 11/2022
2	Antiviral Agents (Antivirals)IBA 01/2023 - 04/2006
2	Proteins (Proteins, Gene)FDA Link 12/2022 - 05/2005
2	AntigensIBA 11/2022 - 01/2007
2	entrectinibIBA 10/2022 - 08/2020
2	Insulin (Novolin)FDA Link 07/2020 - 01/2011
2	Small Interfering RNA (siRNA)IBA 05/2011 - 01/2011
1	Capsules (Microcapsules)IBA 05/2024
1	Sodium-Glucose Transport ProteinsIBA 01/2023
1	ChemokinesIBA 01/2023
1	AlbuminsIBA 01/2023
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2023
1	MetalsIBA 01/2023
1	Angiotensin Receptor AntagonistsIBA 01/2023
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 12/2022
1	Circular RNAIBA 12/2022
1	Dialysis SolutionsIBA 11/2022
1	Sirtuin 1IBA 11/2022
1	Heavy MetalsIBA 01/2022
1	CadmiumIBA 01/2022
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2022
1	ManganeseIBA 01/2022
1	MercuryIBA 01/2022
1	SeleniumIBA 01/2022
1	thiamine triphosphorate (TTP)IBA 11/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 08/2020
1	AntibodiesIBA 07/2020
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 07/2020
1	CholesterolIBA 11/2019
1	Insulin Aspart (NovoLog)FDA Link 02/2019
1	Blood Glucose (Blood Sugar)IBA 02/2019
1	Hypoglycemic Agents (Hypoglycemics)IBA 02/2019
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2019
1	ArsenicIBA 06/2018
1	Long Noncoding RNAIBA 06/2017
1	Oral ContraceptivesIBA 01/2016
1	Insulin ReceptorIBA 01/2016
1	telocinobufaginIBA 04/2015
1	Vaccine AdjuvantsIBA 04/2015
1	MicroRNAs (MicroRNA)IBA 12/2014
1	Tumor Biomarkers (Tumor Markers)IBA 12/2014
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 02/2014
1	CytoglobinIBA 05/2013
1	triphenyltetrazoliumIBA 05/2013
1	OrexinsIBA 11/2012

Therapy/Procedure

6	Therapeutics 05/2024 - 11/2003
1	Peritoneal Dialysis 11/2022
1	Drug Therapy (Chemotherapy) 02/2014
1	Nursing Care 02/2014
1	Laparotomy 11/2012
1	Analgesia 11/2012
1	Electroacupuncture 11/2012